Barclays’s Bolt Biotherapeutics BOLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $0 | Sell |
6
-1
| -14% | – | ﹤0.01% | 4355 |
|
|
2025
Q1 | $0 | Hold |
7
| – | – | ﹤0.01% | 4387 |
|
|
2024
Q4 | $0 | Hold |
7
| – | – | ﹤0.01% | 4361 |
|
|
2024
Q3 | $0 | Hold |
7
| – | – | ﹤0.01% | 4326 |
|
|
2024
Q2 | $0 | Hold |
7
| – | – | ﹤0.01% | 4186 |
|
|
2024
Q1 | $0 | Hold |
7
| – | – | ﹤0.01% | 4164 |
|
|
2023
Q4 | $0 | Hold |
7
| – | – | ﹤0.01% | 4211 |
|
|
2023
Q3 | $0 | Hold |
7
| – | – | ﹤0.01% | 4258 |
|
|
2023
Q2 | $0 | Hold |
7
| – | – | ﹤0.01% | 4253 |
|
|
2023
Q1 | $0 | Sell |
7
-77
| -92% | – | ﹤0.01% | 4301 |
|
|
2022
Q4 | $2K | Buy |
84
+77
| +1,100% | +$1.83K | ﹤0.01% | 4280 |
|
|
2022
Q3 | $0 | Sell |
7
-6
| -46% | – | ﹤0.01% | 4640 |
|
|
2022
Q2 | $0 | Sell |
13
-465
| -97% | – | ﹤0.01% | 4713 |
|
|
2022
Q1 | $26K | Buy |
+478
| New | +$26K | ﹤0.01% | 4234 |
|